Myelodysplastic syndrome evolving to a mixed myeloid-lymphoid leukaemia

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.

Blood cancer journal·2024

Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation.

Leukemia supplements·2016

Results of allogeneic stem cell transplantation in the Spanish MDS registry: prognostic factors for low risk patients.

Leukemia research·2014

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.

Bone marrow transplantation·2014

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Leukemia·2013

Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.

Leukemia·2013

Metabolic Tumor Area: A Clinically Practical Prognostic Marker for Improved Risk Stratification in IPI Non-High-Risk DLBCL.

Hematological oncology·2026

Epigenetic Rewiring and Context-Dependent Therapeutic Vulnerabilities in Myeloproliferative Neoplasms.

Hematological oncology·2026

Circulating Tumor DNA and Immune Response Markers for Improved Treatment Outcome Prediction in Diffuse Large B-Cell Lymphoma: A Scoping Review.

Hematological oncology·2026

Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.

Hematological oncology·2026

Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series.

Hematological oncology·2026

The Transformation of the Microenvironment: From Observer to Coordinator in Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma Development.

Hematological oncology·2026

Flunarizine prevents demyelination and neurological deficits in a cuprizone-induced mouse model of multiple sclerosis.

Indian journal of pharmacology·2026

Impact of atypical antipsychotics on cytokine profiles in schizophrenia: An 8-week longitudinal study.

Indian journal of pharmacology·2026

Gut Epithelial AMPK/SIRT1 Signalling Is Associated With Akkermansia muciniphila-Linked Th17/Treg Reprogramming and Immune Homeostasis After Ischemic Stroke.

Immunology·2026

T Cell-Mediated Targeting of Interneurons in Mice Shapes Hippocampal Remodeling and Epilepsy.

Annals of neurology·2026

Toxoplasmosis-associated hemophagocytic lymphohistiocytosis during tumor-infiltrating lymphocyte therapy.

ASM case reports·2026

Inflammaging and immunosenescence-driven remodeling of the immune microenvironment in osteoarthritis: mechanisms, immune regulation and immune reprogramming.

Frontiers in immunology·2026

Related Experiment Videos

Myelodysplastic syndrome evolving to a mixed myeloid-lymphoid leukaemia

Related Concept Videos

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.

Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation.

Results of allogeneic stem cell transplantation in the Spanish MDS registry: prognostic factors for low risk patients.

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.

Metabolic Tumor Area: A Clinically Practical Prognostic Marker for Improved Risk Stratification in IPI Non-High-Risk DLBCL.

Epigenetic Rewiring and Context-Dependent Therapeutic Vulnerabilities in Myeloproliferative Neoplasms.

Circulating Tumor DNA and Immune Response Markers for Improved Treatment Outcome Prediction in Diffuse Large B-Cell Lymphoma: A Scoping Review.

Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.

Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series.

The Transformation of the Microenvironment: From Observer to Coordinator in Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma Development.

Flunarizine prevents demyelination and neurological deficits in a cuprizone-induced mouse model of multiple sclerosis.

Impact of atypical antipsychotics on cytokine profiles in schizophrenia: An 8-week longitudinal study.

Gut Epithelial AMPK/SIRT1 Signalling Is Associated With Akkermansia muciniphila-Linked Th17/Treg Reprogramming and Immune Homeostasis After Ischemic Stroke.

T Cell-Mediated Targeting of Interneurons in Mice Shapes Hippocampal Remodeling and Epilepsy.

Toxoplasmosis-associated hemophagocytic lymphohistiocytosis during tumor-infiltrating lymphocyte therapy.

Inflammaging and immunosenescence-driven remodeling of the immune microenvironment in osteoarthritis: mechanisms, immune regulation and immune reprogramming.

Related Experiment Videos

Myelodysplastic syndrome evolving to a mixed myeloid-lymphoid leukaemia

Related Concept Videos

Related Articles